ZA-35 37.5 mg (Venlafaxine Extended Release 37.5 mg)

Pill imprint ZA-35 37.5 mg has been identified as Venlafaxine hydrochloride extended release 37.5 mg.

Venlafaxine is used in the treatment of major depressive disorder; hot flashes; anxiety; anxiety and stress; fibromyalgia (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Venlafaxine hydrochloride extended release

Imprint:

ZA-35 37.5 mg

Strength:

37.5 mg

Color:

Gray & White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Serotonin-norepinephrine reuptake inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Zydus Pharmaceuticals USA Inc.

National Drug Code (NDC):

68382-0034

Inactive Ingredients:

silicon dioxide
cetostearyl alcohol
gelatin
hypromelloses
microcrystalline cellulose
ethyl acrylate - methyl methacrylate copolymer
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferrosoferric oxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
60429-0121	Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.